Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (1,569,399)	$ 16,559,619
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	(149,951)	24,741
Realized investment gains, net	(8,973,842)	(6,759,716)
Change in fair value of equity securities	7,209,399	(14,462,029)
Realized trading losses included in income	0	13,283
Amortization of cost of insurance acquired	495,943	516,261
Depreciation and depletion	447,698	1,635,706
Stock-based compensation	674,390	486,797
Charges for mortality and administration of universal life and annuity products	(4,288,294)	(4,480,817)
Interest credited to account balances	2,741,851	2,831,885
Change in accrued investment income	133,627	31,527
Change in reinsurance receivables	865,679	827,435
Change in policy liabilities and accruals	(3,464,745)	(3,074,992)
Change in income taxes receivable (payable)	(6,611,271)	1,378,658
Change in other assets and liabilities, net	2,764,428	4,194,376
Net cash used in operating activities	(9,724,487)	(277,266)
Proceeds from investments sold and matured:
Fixed maturities available for sale	4,058,333	8,628,136
Equity securities	6,861,942	10,735,510
Trading securities	0	17,983
Mortgage loans	17,601,131	1,443,119
Real estate	15,533,712	11,387,025
Notes receivable	4,650,509	3,984,614
Policy loans	1,106,310	903,696
Short-term investments	9,740,815	0
Total proceeds from investments sold and matured	59,552,752	37,100,083
Cost of investments acquired:
Fixed maturities available for sale	0	(1,112,505)
Equity securities	(7,874,161)	(12,540,638)
Trading securities	0	(32,382)
Mortgage loans	(2,050,124)	(1,755,496)
Real estate	(4,115,151)	(4,236,603)
Notes receivable	(3,579,241)	(5,870,657)
Policy loans	(699,167)	(728,348)
Short-term investments	(29,300,034)	0
Total cost of investments acquired	(47,617,878)	(26,276,629)
Net cash provided by investing activities	11,934,874	10,823,454
Cash flows from financing activities:
Policyholder contract deposits	3,144,884	3,455,489
Policyholder contract withdrawals	(3,315,173)	(3,400,630)
Proceeds from notes payable/line of credit	2,500,000	19,500,000
Payments of principal on notes payable/line of credit	(21,500,000)	(35,500,000)
Purchase of treasury stock	(765,048)	(605,230)
Non controlling contributions (distributions) of consolidated subsidiary	0	0
Net cash used in financing activities	(19,935,337)	(16,550,371)
Net decrease in cash and cash equivalents	(17,724,950)	(6,004,183)
Cash and cash equivalents at beginning of period	45,290,385	30,787,278
Cash and cash equivalents at end of period	$ 27,565,435	$ 24,783,095